The9 investee Nanyang Biologics clears vote toward Nasdaq listing
Nanyang Biologics, The9’s investee, advances toward a Nasdaq listing after an RFAI cleared vote at a Shareholders Extraordinary General Meeting.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.